Christina Ackermann, Director at Verona Pharma plc (VRNA), sold 40,000 shares at $8.44 ($338K) on 2025-05-14, disclosed to the SEC on 2025-05-16.
Scheduled sale ($338k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BHC | SELL | 2021-06-04 | $7.7M | — | Filing → |
| BHC | BUY | 2020-03-11 | $160K | — | Filing → |
| BHC | SELL | 2019-08-13 | $153K | — | Filing → |